Clinical Trials | December 07, 2025
Bayer reports promising results for low-dose pediatric MRI contrast agent
MRI is particularly valuable in pediatric care due to its non-invasive nature
MRI is particularly valuable in pediatric care due to its non-invasive nature
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Siponimod Tablets is indicated for the treatment of relapsing forms of multiple sclerosis
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
Growing patent filings and tier-2 innovators reflect expanding national research base
The technology is intended to support imaging-based training, protocol optimisation and surgical planning
Subscribe To Our Newsletter & Stay Updated
